$1.14 Billion is the total value of Perceptive Advisors's 170 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 58.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FOLD | AMICUS THERAPEUTICS | $128,773,000 | -12.9% | 15,239,444 | 0.0% | 11.30% | +3.3% | |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $107,614,000 | -23.8% | 2,720,967 | +9.0% | 9.44% | -9.6% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $74,823,000 | -13.5% | 3,833,128 | +71.1% | 6.56% | +2.6% |
| TSRO | Buy | TESARO INC | $48,374,000 | -4.6% | 1,098,659 | +13.4% | 4.24% | +13.1% |
| AGN | Buy | ALLERGAN PLC | $41,545,000 | -8.3% | 155,000 | +6.9% | 3.64% | +8.7% |
| RTRX | Buy | RETROPHIN INC | $40,971,000 | -17.7% | 2,999,380 | +16.3% | 3.59% | -2.4% |
| XNCR | Sell | XENCOR INC | $24,220,000 | -10.7% | 1,804,784 | -2.7% | 2.12% | +5.9% |
| VSAR | Buy | VERSARTIS INC | $22,742,000 | -20.2% | 2,835,754 | +23.3% | 2.00% | -5.4% |
| XLRN | Buy | ACCELERON PHARMA | $21,192,000 | +57.4% | 803,036 | +190.9% | 1.86% | +86.6% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $20,577,000 | -46.4% | 1,297,468 | +9.3% | 1.80% | -36.4% |
| HUM | New | HUMANA INC | $20,124,000 | – | 110,000 | +100.0% | 1.76% | – |
| NVRO | Sell | NEVRO CORP | $19,612,000 | -40.0% | 348,600 | -28.0% | 1.72% | -28.9% |
| QTNT | Buy | QUOTIENT LTD | $19,132,000 | +33.8% | 2,189,067 | +145.0% | 1.68% | +58.6% |
| ACRX | ACELRX PHARMACEUTICALS | $18,466,000 | -20.0% | 5,995,760 | 0.0% | 1.62% | -5.2% | |
| FPRX | Buy | FIVE PRIME THERAPEUTICS INC | $18,451,000 | +2.4% | 454,129 | +4.6% | 1.62% | +21.4% |
| QURE | Buy | UNIQURE NV | $17,132,000 | +7.1% | 1,442,093 | +49.1% | 1.50% | +27.0% |
| MDVN | New | MEDIVATION INC | $15,633,000 | – | 340,000 | +100.0% | 1.37% | – |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $14,627,000 | -16.6% | 699,515 | +7.7% | 1.28% | -1.1% |
| LBIO | Sell | LION BIOTECHNOLOGIES INC | $14,159,000 | -38.9% | 2,787,256 | -7.1% | 1.24% | -27.5% |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDadr | $13,966,000 | -55.8% | 261,000 | -45.7% | 1.22% | -47.6% |
| DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $13,563,000 | +21.8% | 416,696 | +35.9% | 1.19% | +44.4% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $12,718,000 | -8.1% | 160,000 | +45.5% | 1.12% | +9.0% |
| CPXX | New | CELATOR PHARMACEUTICALS INC | $12,133,000 | – | 1,100,000 | +100.0% | 1.06% | – |
| SRPT | Buy | Sarepta Therapeutics Inccall | $10,736,000 | -44.3% | 550,000 | +10.0% | 0.94% | -34.0% |
| DERM | Buy | DERMIRA INC | $10,588,000 | -39.1% | 512,000 | +2.0% | 0.93% | -27.7% |
| CSU | Buy | CAPITAL SR LIVING CORP | $10,087,000 | -0.0% | 544,636 | +12.6% | 0.88% | +18.5% |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $9,572,000 | -28.6% | 742,021 | +15.6% | 0.84% | -15.2% |
| PFNX | PFENEX INC | $9,446,000 | -20.6% | 960,877 | 0.0% | 0.83% | -5.8% | |
| CDTX | CIDARA THERAPEUTICS INC | $9,434,000 | -26.0% | 742,858 | 0.0% | 0.83% | -12.3% | |
| New | ALDER BIOPHARMACEUTICALS INC | $9,184,000 | – | 375,000 | +100.0% | 0.81% | – | |
| RXDX | Sell | IGNYTA INC | $9,119,000 | -62.4% | 1,347,060 | -25.7% | 0.80% | -55.5% |
| AGTC | Sell | APPLIED GENETIC TECHNOL CORP | $9,095,000 | -48.3% | 650,591 | -24.5% | 0.80% | -38.6% |
| DEPO | Buy | DEPOMED INC | $9,055,000 | -0.1% | 650,000 | +30.0% | 0.79% | +18.3% |
| Sell | BAXTER INTL INC | $9,038,000 | -51.2% | 220,000 | -54.6% | 0.79% | -42.1% | |
| RGNX | Buy | REGENXBIO INC | $8,914,000 | -31.1% | 825,396 | +5.9% | 0.78% | -18.3% |
| ZYNE | Buy | ZYNERBA PHARMACEUTICALS INC | $8,026,000 | +42.7% | 849,350 | +52.1% | 0.70% | +69.2% |
| AKBA | Buy | AKEBIA THERAPEUTICS INC | $7,794,000 | +132.0% | 865,000 | +232.7% | 0.68% | +174.7% |
| VBIV | VBI VACCINES INC | $7,661,000 | -3.7% | 3,260,356 | 0.0% | 0.67% | +14.1% | |
| EGRX | Buy | EAGLE PHARMACEUTICALS INC | $7,582,000 | -35.8% | 187,215 | +40.6% | 0.66% | -23.8% |
| VCEL | Buy | VERICEL CORP | $7,310,000 | +826.5% | 1,247,312 | +308.1% | 0.64% | +1005.2% |
| BPMC | BLUEPRINT MEDICINES CORP | $7,299,000 | -31.5% | 404,404 | 0.0% | 0.64% | -18.8% | |
| Buy | BAXTER INTERNATIONAL INCcall | $7,168,000 | +87.9% | 175,400 | +75.4% | 0.63% | +123.0% | |
| PSDV | Buy | PSIVIDA CORPORATION | $7,142,000 | +257.1% | 2,665,000 | +542.2% | 0.63% | +323.0% |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $7,137,000 | – | 255,240 | +100.0% | 0.63% | – |
| NEPT | Buy | NEPTUNE TECHNOLOGIES BIORESO | $6,750,000 | -5.8% | 6,750,444 | +0.7% | 0.59% | +11.7% |
| ANI PHARMACEUTICALS INCnote 3.000%12/0 | $6,590,000 | -11.7% | 7,500,000 | 0.0% | 0.58% | +4.7% | ||
| EVH | Buy | EVOLENT HEALTH INCcl a | $6,536,000 | +265.8% | 618,930 | +319.3% | 0.57% | +334.1% |
| NVO | Buy | NOVO-NORDISK A Sadr | $6,322,000 | +1041.2% | 116,660 | +1122.9% | 0.56% | +1253.7% |
| MRTX | New | MIRATI THERAPEUTICS INC | $5,842,000 | – | 273,000 | +100.0% | 0.51% | – |
| HZNP | New | HORIZON PHARMA PLC | $5,800,000 | – | 350,000 | +100.0% | 0.51% | – |
| NVRO | New | NEVRO CORPcall | $5,626,000 | – | 100,000 | +100.0% | 0.49% | – |
| AXGT | Sell | AXOVANT SCIENCES LTD | $5,568,000 | -42.3% | 485,000 | -9.3% | 0.49% | -31.7% |
| ANTH | Buy | ANTHERA PHARMACEUTICALS INC | $5,402,000 | +17.3% | 1,492,156 | +50.4% | 0.47% | +39.0% |
| MYOK | Sell | MYOKARDIA INC | $5,385,000 | -27.0% | 502,894 | -0.0% | 0.47% | -13.4% |
| ALDX | ALDEYRA THERAPEUTICS INC | $5,197,000 | -38.2% | 1,240,458 | 0.0% | 0.46% | -26.7% | |
| CELG | New | CELGENE CORP | $5,005,000 | – | 50,000 | +100.0% | 0.44% | – |
| NERV | MINERVA NEUROSCIENCES INC | $4,976,000 | +1.2% | 810,537 | 0.0% | 0.44% | +19.8% | |
| New | ALDER BIOPHARMACEUTICALS INCput | $4,898,000 | – | 200,000 | +100.0% | 0.43% | – | |
| ABEO | ABEONA THERAPEUTICS INC | $4,512,000 | -23.8% | 1,762,881 | 0.0% | 0.40% | -9.6% | |
| Sell | AMGEN INC | $4,498,000 | -44.6% | 30,000 | -40.0% | 0.40% | -34.3% | |
| ONTY | ONCOTHYREON INC | $4,335,000 | -42.8% | 3,414,121 | 0.0% | 0.38% | -32.3% | |
| AVXS | New | AVEXIS INC | $4,086,000 | – | 150,000 | +100.0% | 0.36% | – |
| GNCA | New | GENOCEA BIOSCIENCES INC | $3,999,000 | – | 516,618 | +100.0% | 0.35% | – |
| ASSEMBLY BIOSCIENCES INC | $3,991,000 | -33.1% | 795,000 | 0.0% | 0.35% | -20.8% | ||
| ADHD | ALCOBRA LTD | $3,897,000 | -39.7% | 1,028,272 | 0.0% | 0.34% | -28.5% | |
| SPNC | Sell | SPECTRANETICS CORP | $3,877,000 | -4.5% | 267,070 | -0.9% | 0.34% | +13.3% |
| ANIP | Buy | ANI PHARMACEUTICALS INC | $3,839,000 | +564.2% | 114,060 | +791.1% | 0.34% | +683.7% |
| NEURODERM LTD | $3,812,000 | -17.2% | 270,000 | 0.0% | 0.33% | -2.1% | ||
| IMMU | Buy | IMMUNOMEDICS INC | $3,550,000 | +478.2% | 1,420,000 | +610.0% | 0.31% | +591.1% |
| OTIC | Buy | OTONOMY INC | $3,521,000 | -38.4% | 235,986 | +14.6% | 0.31% | -27.0% |
| ZLTQ | New | ZELTIQ AESTHETICS INC | $3,314,000 | – | 122,000 | +100.0% | 0.29% | – |
| FWP | New | FORWARD PHARMA A/Ssponsored adr | $3,167,000 | – | 186,300 | +100.0% | 0.28% | – |
| OMER | New | OMEROS CORP | $3,068,000 | – | 200,000 | +100.0% | 0.27% | – |
| New | AFFIMED THERAPEUTICS BVsponsored adr | $3,071,000 | – | 821,201 | +100.0% | 0.27% | – | |
| SUPN | New | SUPERNUS PHARMACEUTICALS INC | $3,050,000 | – | 200,000 | +100.0% | 0.27% | – |
| WBA | WALGREENS BOOTS ALLIANCE INC | $2,973,000 | -1.1% | 35,292 | 0.0% | 0.26% | +17.6% | |
| ACAD | New | ACADIA PHARMACEUTICALS INCput | $2,796,000 | – | 200,000 | +100.0% | 0.24% | – |
| TKAI | TOKAI PHARMACEUTICALS INC | $2,723,000 | -35.7% | 485,338 | 0.0% | 0.24% | -23.6% | |
| CEMP | New | CEMPRA INC | $2,628,000 | – | 150,000 | +100.0% | 0.23% | – |
| ARDELYX INC | $2,455,000 | -57.1% | 315,955 | 0.0% | 0.22% | -49.3% | ||
| WVE | New | WAVE LIFE SCIENCES LTD | $2,443,000 | – | 176,000 | +100.0% | 0.21% | – |
| PTI | New | PROTEOSTASIS THERAPEUTICS IN | $2,410,000 | – | 250,000 | +100.0% | 0.21% | – |
| CRBP | CORBUS PHARMACEUTICALS INC | $2,262,000 | +9.7% | 1,250,000 | 0.0% | 0.20% | +29.4% | |
| RGLS | New | REGULUS THERAPEUTICS INC | $2,256,000 | – | 325,407 | +100.0% | 0.20% | – |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $2,229,000 | – | 20,000 | +100.0% | 0.20% | – |
| PRTO | PROTEON THERAPEUTICS INC | $2,129,000 | -50.1% | 275,000 | 0.0% | 0.19% | -40.8% | |
| MGCD | MGC DIAGNOSTICS CORP | $2,045,000 | -7.6% | 336,287 | 0.0% | 0.18% | +9.1% | |
| DXCM | New | DEXCOM INC | $1,798,000 | – | 26,474 | +100.0% | 0.16% | – |
| EIGR | New | EIGER BIOPHARMACEUTICALS INC | $1,759,000 | – | 104,920 | +100.0% | 0.15% | – |
| CBPO | New | CHINA BIOLOGIC PRODS INC | $1,603,000 | – | 14,000 | +100.0% | 0.14% | – |
| PETX | New | ARATANA THERAPEUTICS INC | $1,611,000 | – | 291,800 | +100.0% | 0.14% | – |
| ALLIQUA BIOMEDICAL INC | $1,575,000 | -61.7% | 1,921,951 | 0.0% | 0.14% | -54.6% | ||
| XENE | XENON PHARMACEUTICALS INC | $1,438,000 | -13.1% | 205,800 | 0.0% | 0.13% | +3.3% | |
| ARNO THERAPEUTIC INC | $1,361,000 | +14.0% | 3,463,292 | 0.0% | 0.12% | +35.2% | ||
| CSBR | CHAMPIONS ONCOLOGY INC | $1,356,000 | +2.0% | 372,597 | 0.0% | 0.12% | +21.4% | |
| DSCI | Buy | DERMA SCIENCES INC | $1,341,000 | -27.2% | 432,884 | +7.4% | 0.12% | -13.2% |
| NVTA | Sell | INVITAE CORP | $1,211,000 | +2.9% | 118,366 | -17.4% | 0.11% | +21.8% |
| NEOS | Sell | NEOS THERAPEUTICS INC | $1,079,000 | -47.2% | 100,000 | -29.9% | 0.10% | -37.1% |
| AGRX | New | AGILE THERAPEUTICS INC | $1,087,000 | – | 175,000 | +100.0% | 0.10% | – |
| BCLI | New | BRAINSTORM CELL THERAPEUTICS | $1,068,000 | – | 400,000 | +100.0% | 0.09% | – |
| VXX | New | BARCLAYS BK PLCipath s&p500 vix | $1,057,000 | – | 60,000 | +100.0% | 0.09% | – |
| ABEOW | ABEONA THERAPEUTICS INC*w exp 12/19/201 | $1,027,000 | -38.0% | 1,259,636 | 0.0% | 0.09% | -26.8% | |
| GWPH | New | GW PHARMACEUTICALS PLCads | $946,000 | – | 13,109 | +100.0% | 0.08% | – |
| ABMD | New | ABIOMED INC | $920,000 | – | 9,700 | +100.0% | 0.08% | – |
| Sell | INTEC PHARMA LTD JERUSALEM | $795,000 | -46.1% | 192,580 | -30.0% | 0.07% | -35.8% | |
| CGNT | COGENTIX MED INC | $741,000 | -14.7% | 673,257 | 0.0% | 0.06% | +1.6% | |
| SCYX | SCYNEXIS INC | $705,000 | -35.1% | 175,000 | 0.0% | 0.06% | -22.5% | |
| VNDA | VANDA PHARMACEUTICALS INC | $601,000 | -10.2% | 71,849 | 0.0% | 0.05% | +8.2% | |
| MGLN | Buy | MAGELLAN HEALTH INC | $596,000 | +187.9% | 8,772 | +161.8% | 0.05% | +246.7% |
| AMN | New | AMN HEALTHCARE SERVICES INC | $586,000 | – | 17,428 | +100.0% | 0.05% | – |
| ICLR | Buy | ICON PLC | $570,000 | +231.4% | 7,585 | +242.7% | 0.05% | +284.6% |
| HCA | New | HCA HOLDINGS INC | $561,000 | – | 7,186 | +100.0% | 0.05% | – |
| UNH | Buy | UNITEDHEALTH GROUP INC | $560,000 | +190.2% | 4,346 | +165.0% | 0.05% | +250.0% |
| GILD | Buy | GILEAD SCIENCES INC | $553,000 | +122.1% | 6,024 | +145.2% | 0.05% | +172.2% |
| New | ANTHEM INC | $521,000 | – | 3,747 | +100.0% | 0.05% | – | |
| MOH | Buy | MOLINA HEALTHCARE INC | $519,000 | +208.9% | 8,052 | +187.6% | 0.05% | +283.3% |
| NVLS | NIVALIS THERAPEUTICS INC | $521,000 | -46.2% | 125,000 | 0.0% | 0.05% | -36.1% | |
| INFI | Buy | INFINITY PHARMACEUTICALS INC | $527,000 | +235.7% | 100,000 | +400.0% | 0.05% | +283.3% |
| AQXP | AQUINOX PHARMACEUTICALS INC | $526,000 | -29.3% | 59,600 | 0.0% | 0.05% | -16.4% | |
| ENTA | New | ENANTA PHARMACEUTICALS INC | $514,000 | – | 17,507 | +100.0% | 0.04% | – |
| HOLX | New | HOLOGIC INC | $508,000 | – | 14,732 | +100.0% | 0.04% | – |
| Buy | AMEDISYS INC | $507,000 | +177.0% | 10,493 | +125.8% | 0.04% | +214.3% | |
| MCK | Buy | MCKESSON CORP | $501,000 | +115.0% | 3,188 | +170.4% | 0.04% | +158.8% |
| UHS | New | UNIVERSAL HLTH SVCS INCcl b | $498,000 | – | 3,989 | +100.0% | 0.04% | – |
| VWR | New | VWR CORP | $505,000 | – | 18,657 | +100.0% | 0.04% | – |
| FCAU | FIAT CHRYSLER AUTOMOBILES N | $500,000 | -42.3% | 62,000 | 0.0% | 0.04% | -31.2% | |
| PRAH | New | PRA HEALTH SCIENCES INC | $502,000 | – | 11,751 | +100.0% | 0.04% | – |
| WCG | New | WELLCARE HEALTH PLANS INC | $505,000 | – | 5,448 | +100.0% | 0.04% | – |
| Q | Buy | QUINTILES TRANSNATIO HLDGS I | $485,000 | +162.2% | 7,447 | +176.0% | 0.04% | +207.1% |
| TARO | Buy | TARO PHARMACEUTICAL INDS LTD | $491,000 | +112.6% | 3,429 | +129.7% | 0.04% | +152.9% |
| INCR | New | INC RESH HLDGS INCcl a | $488,000 | – | 11,846 | +100.0% | 0.04% | – |
| CAH | New | CARDINAL HEALTH INC | $487,000 | – | 5,947 | +100.0% | 0.04% | – |
| Buy | ALMOST FAMILY INC | $487,000 | +160.4% | 13,075 | +167.4% | 0.04% | +207.1% | |
| GNVC | Sell | GENVEC INC | $489,000 | -56.8% | 606,644 | -1.5% | 0.04% | -48.8% |
| CRL | Buy | CHARLES RIV LABS INTL INC | $474,000 | +73.0% | 6,244 | +83.1% | 0.04% | +110.0% |
| MACK | MERRIMACK PHARMACEUTICALS IN | $419,000 | +6.1% | 50,000 | 0.0% | 0.04% | +27.6% | |
| PMC | Buy | PHARMERICA CORP | $372,000 | +56.3% | 16,841 | +147.7% | 0.03% | +83.3% |
| STML | STEMLINE THERAPEUTICS INC | $366,000 | -26.2% | 78,603 | 0.0% | 0.03% | -13.5% | |
| GLMD | GALMED PHARMACEUTICALS LTD | $369,000 | -35.4% | 75,000 | 0.0% | 0.03% | -23.8% | |
| ACST | ACASTI PHARMA INCcl a new | $360,000 | -39.4% | 236,559 | 0.0% | 0.03% | -27.3% | |
| SPY | New | SPDR S&P 500 ETF TRtr unit | $329,000 | – | 1,600 | +100.0% | 0.03% | – |
| APHB | Buy | AMPLIPHI BIOSCIENCES CORP | $315,000 | +5.7% | 80,000 | +7.0% | 0.03% | +27.3% |
| CNC | Buy | CENTENE CORP DEL | $305,000 | +78.4% | 4,948 | +90.8% | 0.03% | +107.7% |
| BVX | BOVIE MEDICAL CORP | $272,000 | -20.5% | 162,700 | 0.0% | 0.02% | -4.0% | |
| TRILLIUM THERAPEUTICS INC | $278,000 | -26.5% | 30,000 | 0.0% | 0.02% | -14.3% | ||
| VTL | New | VITAL THERAPIES INC | $271,000 | – | 29,968 | +100.0% | 0.02% | – |
| DRNA | DICERNA PHARMACEUTICALS INC | $268,000 | -54.9% | 50,000 | 0.0% | 0.02% | -45.5% | |
| GTS | TRIPLE-S MGMT CORPcl b | $264,000 | +3.9% | 10,605 | 0.0% | 0.02% | +21.1% | |
| RACE | New | FERRARI N V | $259,000 | – | 6,200 | +100.0% | 0.02% | – |
| TNDM | TANDEM DIABETES CARE INC | $217,000 | -26.4% | 25,000 | 0.0% | 0.02% | -13.6% | |
| ELGX | Sell | ENDOLOGIX INC | $209,000 | -93.0% | 25,000 | -91.7% | 0.02% | -91.8% |
| AKAOQ | New | ACHAOGEN INC | $166,000 | – | 60,000 | +100.0% | 0.02% | – |
| CRIS | CURIS INC | $161,000 | -44.7% | 100,000 | 0.0% | 0.01% | -36.4% | |
| MNKKQ | New | MALLINCKRODT PUB LTD CO | $164,000 | – | 2,673 | +100.0% | 0.01% | – |
| FONR | FONAR CORP | $130,000 | -11.0% | 8,473 | 0.0% | 0.01% | 0.0% | |
| DRAD | DIGIRAD CORP | $124,000 | -14.5% | 24,988 | 0.0% | 0.01% | 0.0% | |
| GI | New | ENDOCHOICE HLDGS INC | $130,000 | – | 25,000 | +100.0% | 0.01% | – |
| MYGN | Buy | MYRIAD GENETICS INC | $125,000 | +15.7% | 3,333 | +33.3% | 0.01% | +37.5% |
| AAVL | New | AVALANCHE BIOTECHNOLOGIES IN | $103,000 | – | 20,000 | +100.0% | 0.01% | – |
| CLLS | CELLECTIS S Asponsored ads | $82,000 | -11.8% | 2,996 | 0.0% | 0.01% | 0.0% | |
| HLF | New | HERBALIFE LTD | $77,000 | – | 1,250 | +100.0% | 0.01% | – |
| CPRX | Sell | CATALYST PHARMACEUTICALS INC | $60,000 | -97.1% | 51,200 | -94.0% | 0.01% | -96.8% |
| NSPH | NANOSPHERE INC | $28,000 | +27.3% | 35,379 | 0.0% | 0.00% | 0.0% | |
| SCMP | SUCAMPO PHARMACEUTICALS INCcl a | $8,000 | -38.5% | 759 | 0.0% | 0.00% | 0.0% | |
| CAPR | CAPRICOR THERAPEUTICS INC | $10,000 | -16.7% | 4,000 | 0.0% | 0.00% | 0.0% | |
| INGN | INOGEN INC | $6,000 | +20.0% | 125 | 0.0% | 0.00% | – | |
| PPHM | New | PEREGRINE PHARMACEUTICALS IN | $10,000 | – | 24,332 | +100.0% | 0.00% | – |
| ZBH | New | ZIMMER BIOMET HLDGS INC | $17,000 | – | 156 | +100.0% | 0.00% | – |
| TTNP | Sell | TITAN PHARMACEUTICALS INC DE | $0 | -100.0% | 1 | -100.0% | 0.00% | -100.0% |
| FLKS | FLEX PHARMA INC | $3,000 | 0.0% | 237 | 0.0% | 0.00% | – | |
| AXDX | Exit | ACCELERATE DIAGNOSTICS INC | $0 | – | -750 | -100.0% | -0.00% | – |
| IDRA | Exit | IDERA PHARMACEUTICALS INC | $0 | – | -4,578 | -100.0% | -0.00% | – |
| UTMD | Exit | UTAH MED PRODS INC | $0 | – | -1,828 | -100.0% | -0.01% | – |
| LNTH | Exit | LANTHEUS HLDGS INC | $0 | – | -38,784 | -100.0% | -0.01% | – |
| LHCG | Exit | LHC GROUP INC | $0 | – | -3,705 | -100.0% | -0.01% | – |
| LCI | Exit | LANNET INC | $0 | – | -4,182 | -100.0% | -0.01% | – |
| AMSG | Exit | AMSURG CORP | $0 | – | -2,243 | -100.0% | -0.01% | – |
| CYH | Exit | COMMUNITY HEALTH SYS INC NEW | $0 | – | -6,724 | -100.0% | -0.01% | – |
| NK | Exit | NANTKWEST INC | $0 | – | -10,000 | -100.0% | -0.01% | – |
| EXAC | Exit | EXACTECH INC | $0 | – | -10,734 | -100.0% | -0.01% | – |
| SCAI | Exit | SURGICAL CARE AFFILIATES INC | $0 | – | -5,133 | -100.0% | -0.02% | – |
| WOOF | Exit | VCA INC | $0 | – | -3,731 | -100.0% | -0.02% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -648 | -100.0% | -0.02% | – |
| ENSG | Exit | ENSIGN GROUP INC | $0 | – | -8,744 | -100.0% | -0.02% | – |
| ABC | Exit | AMERISOURCEBERGEN CORP | $0 | – | -2,030 | -100.0% | -0.02% | – |
| LPNT | Exit | LIFEPOINT HEALTH INC | $0 | – | -2,862 | -100.0% | -0.02% | – |
| CBM | Exit | CAMBREX CORP | $0 | – | -4,692 | -100.0% | -0.02% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -6,927 | -100.0% | -0.02% | – |
| GB | Exit | GREATBATCH INC | $0 | – | -4,391 | -100.0% | -0.02% | – |
| CRVL | Exit | CORVEL CORP | $0 | – | -5,115 | -100.0% | -0.02% | – |
| HNT | Exit | HEALTH NET INC | $0 | – | -3,831 | -100.0% | -0.02% | – |
| ARIA | Exit | ARIAD PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.02% | – |
| Exit | ACHAOGEN INC | $0 | – | -60,000 | -100.0% | -0.02% | – | |
| Exit | AVINGER INC | $0 | – | -19,566 | -100.0% | -0.03% | – | |
| XIV | Exit | CREDIT SUISSE NASSAU BRHinvrs vix sterm | $0 | – | -25,000 | -100.0% | -0.05% | – |
| BCLI | Exit | BRAINSTORM CELL THERAPEUTICS | $0 | – | -400,000 | -100.0% | -0.08% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -20,000 | -100.0% | -0.09% | – |
| HEWG | Exit | ISHARES TRhdg msci germn | $0 | – | -100,000 | -100.0% | -0.18% | – |
| MDCO | Exit | MEDICINES CO | $0 | – | -75,000 | -100.0% | -0.21% | – |
| CI | Exit | CIGNA CORPORATION | $0 | – | -20,000 | -100.0% | -0.22% | – |
| VTAE | Exit | VITAE PHARMACEUTICALS INC | $0 | – | -200,000 | -100.0% | -0.27% | – |
| SRPT | Exit | Sarepta Therapeutics Incput | $0 | – | -100,000 | -100.0% | -0.28% | – |
| TRXC | Exit | TRANSENTERIX INC | $0 | – | -1,715,941 | -100.0% | -0.32% | – |
| AFMD | Exit | AFFIMED N V | $0 | – | -868,820 | -100.0% | -0.46% | – |
| Exit | BELLICUM PHARMACEUTICALS | $0 | – | -421,188 | -100.0% | -0.63% | – | |
| Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -245,240 | -100.0% | -0.65% | – | |
| GWPH | Exit | GW PHARMACEUTICALS -ADRput | $0 | – | -400,000 | -100.0% | -2.06% | – |
| DYAX | Exit | DYAX CORP | $0 | – | -1,819,215 | -100.0% | -5.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
| AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
| ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
| QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
| GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
| ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
| RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
| DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
| VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
| VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
| Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
| REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
| AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
| ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
| BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
| CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
| Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-04-17 |
| 4 | 2024-04-15 |
| SC 13G/A | 2024-04-15 |
| SC 13G | 2024-04-15 |
| SC 13D/A | 2024-04-10 |
| 4 | 2024-04-08 |
| 4 | 2024-04-03 |
| SC 13D/A | 2024-04-03 |
| SC 13D | 2024-03-20 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.